 Codex DNA Inc NASDAQ: DNAY has announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences Holdings Inc NASDAQ: MRVI for CleanCap technology. Codex DNA will integrate the mRNA capping technology into its suite of automated mRNA synthesis kits for the BioXp system and within the companys BioFoundry Services offering. 